Feasibility of Using Low-Volume Tissue Samples for Gene Expression Profiling of Advanced Non-Small Cell Lung Cancers

Clinical Cancer Research

Volumn 9, Issue 16 I, 2003, Pages 5980-5987

  Lim, Elaine H ^a   Aggarwal, Amit ^b   Agasthian, Thirugananam ^b   Wong, Poo Sing ^a   Tan, Christie ^a   Sim, Eugene ^a   Tan, Lenny ^a   Goh, Poh Sun ^a   Wang, Shih Chang ^a   Khoo, Kay Leong ^a   Mukherjee, Amartya ^a   Khoo, See Meng ^a   Chua, Gerald ^a   Nilsson, Barbro ^a   Lee, Kang Hoe ^a   Tan, Patrick ^b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ARTICLE; ASPIRATION BIOPSY; CANCER STAGING; CLINICAL PROTOCOL; CONTROLLED STUDY; DNA MICROARRAY; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MOLECULAR BIOLOGY; PRIORITY JOURNAL; SAMPLE SIZE; STANDARDIZATION;

BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; FEASIBILITY STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA; RNA, MESSENGER;

EID: 0347995047     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Parkin, D. M., Pisani, P., and Ferlay, J. Global cancer statistics. CA - Cancer J. Clin., 49: 33-64, 1999.
2. Schiller, J. H., Harrington, D., Belani, C. P., Langer, C., Sandler, A., Krook, J., Zhu, J., and Johnson, D. H. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N. Engl. J. Med., 346: 92-98, 2002.
3. Fukuoka, M., Furuse, K., Saijo, N., Nishiwaki, Y., Ikegami, H., Tamura, T., Shimoyama, M., and Suemasu, K. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J. Natl. Cancer Inst. (Bethesda), 83: 855-861, 1991.
4. DeRisi, J., Penland, L., and Brown, P. O. (Group 1), Bitmer, M. L., Meltzer, P. S., Ray, M.; Chen, Y., Su Y. A., and Trent, J. M. (Group 2). Use of a cDNA microarray to analyze gene expression patterns in human cancer. Nat. Genet., 14: 457-460, 1996.
5. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., Powell, J. I., Yang, L., Marti, G. E., Moore, T., Hudson, J., Lu, L., Lewis, D. B., Tibshirani, R., Sherlock, G., Chan, W. C., Greiner, T. C., Weisenburger, D. D., Armitage, J. O., Warnke, R., Levy, R., Wilson, W., Grever, W. R., Byrd, J. C., Botstein, D., Brown, P. O., and Staudt, L. M. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (Lond.), 403: 503-511, 2000.
6. van de Vijver, M. J., He, Y. D., van't Veer, L. J., Dai, H., Hart, A. A., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., Parrish, M., Atsma, D., Witteveen, A., Glas, A., Delahaye, L., van der Velde, T., Bartelink, H., Rodenhuis, S., Rutgers, E. T., Friend, S. H., and Bernards, R. A gene expression signature as a predictor of survival in breast cancer. N. Engl. J. Med., 347: 1999-2009, 2002.
7. Garber, M. E., Troyanskaya, O. G., Schluens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G. D., Perou, C. M., Whyte, R. I., Altman, R. B., Brown, P. O., Botstein, D., and Petersen, I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA, 98: 13784-13789, 2001.
8. Bhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., Loda, M., Weber, G., Mark, E. J., Lander, E. S., Wong, W., Johnson, B. E., Golub, T. R., Sugarbaker, D. J., and Meyerson, M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA, 98: 13790-13795, 2001.
9. Giordano, T. J., Shedden, K. A., Schwartz, D. R., Kuick, R., Taylor, J. M. G., Lee, N., Misek, D. E., Greenson, J. K., Kardia, S. L. R., Beer, D. G., Rennert, G., Cho, K. R., Gruber, S. B., Fearon, E. R., and Hanash, S. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am. J. Pathol., 159: 1231-1238, 2001.
10. Nacht, M., Dracheva, T., Gao, Y., Fuji, T., Chen, Y., Player, A., Akmaev, V., Cook, B., Dufault, M., Zhang, M., Zhang, W., Guo, M., Curran, J., Han, S., Sidransky, D., Buetow, K., Madden, S. L., and Jen, J. Molecular characteristics of non-small cell lung cancer. Proc. Natl. Acad. Sci. USA, 98: 15203-15208, 2001.
11. Beer, D. G., Kardia, S. L. R., Huang, C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., Lizyness, M. L., Kuick, R., Hayasaka, S., Taylor, J. M. G., Iannettoni, M. D., Orringer, M. B., and Hanash, S. Gene expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med., 8: 816-824, 2002.
12. Heighway, J., Knapp, T., Boyce, L., Brennand, S., Field, J. K., Betticher, D. C., Ratschiller, D., Gugger, M., Donovan, M., Lasek, A., and Rickert, P. Expression profiling of primary non-small cell lung cancer for target identification. Oncogene, 21: 7749-7763, 2002.
13. Wang, E., Miller, L. D., Ohnmacht, G. A., Liu, E. T., and Marincola, F. M. High-fidelity mRNA amplification for gene profiling. Nat. Biotech., 18: 457-459, 2000.
14. Wang, E., Miller, L. D., Ohnmacht, G. A., Mocellin, S., Perez-Diez, A., Petersen, D., Zhao, Y., Simon, R., Powell, J. I., Asaki, E., Alexander, H. R., Duray, P. H., Herlyn, M., Restifo, N. P., Liu, E. T., Rosenberg, S. A., and Marincola, F. M. Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Res., 62: 3581-3586, 2002.
15. Sotiriou, C., Powles, T. J., Dowsett, M., Jazaeri, A. A., Feldman, A. L., Assersohn, L., Gadisetti, C., Libutti, S. K., and Liu, E. T. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer. Breast Cancer Res., 4: R3, 2002.
16. Vapnik, V. Statistical Learning Theory. New York: Wiley, 1998.
17. Cristianini, N., and Shawe-Taylor, J. An Introduction to Support Vector Machines. Cambridge, United Kingdom: Cambridge University Press, 2000.
18. Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., Yeang, C-H., Angelo, M., Ladd, C., Reich, M., Latulippe, E., Mesirov, J. P., Poggio, T., Gerald, W., Loda, M., Lander, E. S., and Golub, T. R. Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl. Acad. Sci. USA, 98: 15149-15154, 2001.
19. Brown, M. P. S., Grundy, W. N., Lin, D., Cristianini, N., Sugnet, C. W., Furey, T. S., Ares, M., Jr., and Haussler, D. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc. Natl. Acad. Sci. USA, 97: 262-267, 2000.
20. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA, 95: 14863-14868, 1998.
21. Jolliffe, I. T. Principal Component Analysis. New York: Springer Verlag, 2002.
22. Basilevsky, A. Statistical Factor Analysis and Related Methods: Theory and Applications. New York: John Wiley and Sons, 1994.
23. Crescenzi, M., and Giuliani, A. The main biological determinants of tumor line taxonomy elucidated by a principal component analysis of microarray data. FEBS Lett., 507: 114-118, 2001.
24. Pelosi, G., Fraggetta, F., Pasini, F., Maisonneuve, P., Sonzogni, A., Iannucci, A., Terzi, A., Bresaola, E., Valduga, F., Lupo, C., and Viale, G. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am. J. Surg. Pathol., 25: 363-372, 2001.
25. Cook, M., Buhling, F., Ansorge, S., Tatnell, P. J., and Kay, J. Pronapsin A and B gene expression in normal and malignant human lung and mononuclear blood cells. Biochim. Biophys. Acta, 1577: 10-16, 2002.
26. Kalinichenko, V. V., Zhou, Y., Shin, B., Stolz, D. B., Watkins, S. C., Whitsett, J. A., and Costa, R. H. Wild-type levels of the mouse Forkhead Box f1 gene are essential for lung repair Am. J. Physiol. Lung Cell Mol. Physiol., 282: L1253-L1265, 2002.
27. LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., and Harlow, E. New functional activities for the p21 family of CDK inhibitors. Genes Dev., 11: 847-862, 1997.
28. 2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene, 22: 1822-1835, 2003.
29. Gelman, I. H. The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development. Front Biosci. 7: 1782-1797, 2002.
30. Suzuki, C., Unoki, M., and Nakamura, Y. Identification and allelic frequencies of novel single-nucleotide polymorphisms in the DUSP1 and BTG1 genes. J. Hum. Genet., 46: 155-157, 2001.
31. Davies, M. A., Kim, S. J., Parikh, N. U., Dong, Z., Bucana, C. D., and Gallick, G. E. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Clin. Cancer Res., 8: 1904-1914, 2002.
32. Baker, S. J., and Reddy, E. P. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene, 12: 1-9, 1996.
33. Pezzella, F., Pastorino, U., Tagliabue, E., Andreola, S., Sozzi, G., Gasparini, G., Menard, S., Gatter, K. C., Harris, A. L., Fox, S., Buyse, M., Pilotti, S., Pierotti, M., and Rilke, F. Non-small cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am. J. Pathol., 151: 1417-1423, 1997.
34. Offersen, B. V., Pfeiffer, P., Hamilton-Dutoit, S., and Overgaard, J. Patterns of angiogenesis in non-small cell lung carcinoma. Cancer (Phila.), 91: 1500-1509, 2001.
35. Passalidou, E., Trivella, M., Singh, N., Ferguson, M., Hu, J., Cesario, A., Granone, P., Nicholson, A. G., Goldstraw, P., Ratcliffe, C., Tetlow, M., Leigh, I., Harris, A. L., Gatter, K. C., and Pezzella, F. Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas. Br. J. Cancer, 86: 244-249, 2002.
36. Tsai, M. S., Bogart, D. F., Castaneda, J. M., Li, P., and Lupu, R. Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene, 21: 8178-8185, 2002.
37. Apte, S. S., Olsen, B. R., and Murphy, G. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J. Biol. Chem., 270: 14313-14318, 1995.
38. Denhardt, D. T., Mistretta, D., Chambers, A. F., Krishna, S., Porter, J. F., Raghuram, S., and Rittling, S. R. Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a ras-activated enhancer in the human OPN promoter. Clin. Exp. Metastasis, 20: 77-84, 2003.
39. Degot, S., Regnier, C. H., Wendling, C., Chenard, M. P., Rio, M. C., and Tomasetto, C. Metastatic lymph node 51, a novel nucleocytoplasmic protein overexpressed in breast cancer. Oncogene, 21: 4422-4434, 2002.
40. Cabibbo, A., Pagani, M., Fabbri, M., Rocchi, M., Farmery, M. R., Bulleid, N. J., and Sitia, R. ERO-L, a human protein that favors disulfide bond formation in the endoplasmic reticulum. J. Biol. Chem., 275: 4827-4833, 2000.
41. Schaake-Koning, C., van den Bogaert, W., Dalesio, O., Festen, J., Hoogenhout, J., van Houtte, P., Kirkpatrick, A., Koolen, M., Maat, B., Nijs, A., Renaud, A., Rodrigus, P., Schuster-Uitterhoeve, L., Sculier, J-P., van Zandwijk, N., and Bartelink, H. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N. Engl. J. Med., 326: 524-530, 1992.
42. Rosell, R., Gomez-Codina, J., Camps, C., Maestre, J., Padille, J., Canto, A., Mate, J. L., Li, S., Roig, J., Olazabal, A., Canela, M., Ariza, A., Skacel, Z., Morera-Prat, J., and Abad, A. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N. Engl. J. Med., 330: 153-158, 1994.
43. Seow, A., Duffy, S. W., Ng, T. P., McGee, M. A., and Lee, H. P. Lung cancer among Chinese females in Singapore 1968-1992: time trends, dialect group differences and implications for aetiology. Int. J. Epidemiol., 27: 167-172, 1998.